-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Financial App News, Federal Pharmaceutical (03933.HK) issued an announcement. UBT48128 tablets, a Class 1 innovative drug independently developed by Federal Biotechnology (Zhuhai Hengqin) Co., Ltd., a wholly-owned subsidiary of the company, have obtained implied approval from the China National Drug Administration for clinical trials of new drugs. The acceptance numbers are CXHL2601252, CXHL2601253 and CXHL2601254.

Zhitongcaijing·11/19/2026 14:01:24
Listen to the news
Zhitong Financial App News, Federal Pharmaceutical (03933.HK) issued an announcement. UBT48128 tablets, a Class 1 innovative drug independently developed by Federal Biotechnology (Zhuhai Hengqin) Co., Ltd., a wholly-owned subsidiary of the company, have obtained implied approval from the China National Drug Administration for clinical trials of new drugs. The acceptance numbers are CXHL2601252, CXHL2601253 and CXHL2601254.